Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report, Osteoporos Int, vol.4, issue.6, pp.368-81, 1994. ,
Ostéodensitométrie sur 2 sites par méthode biphotonique, 2006. ,
Actualisation 2012 des recommandations françaises du traitement médicamenteux de l'ostéoporose postménopausique, Rev Rhum, vol.79, issue.3, pp.264-74, 2012. ,
Les médicaments de l'ostéoporose -Fiche Bon Usage du médicament, 2014. ,
, Agence française de sécurité sanitaire des produits de santé. Traitement médicamenteux de l'osteoporose post-ménauposique, 2006.
Osteoporosis in the European Union: a compendium of country-specific reports, Arch Osteoporos, vol.8, issue.1-2, p.137, 2013. ,
Recent Advances in the Pathogenesis and Treatment of Osteoporosis, Clin Med Lond Engl, vol.16, issue.4, pp.360-364, 2016. ,
Ostéoporoses secondaires en médecine interne, Rev Médecine Interne, vol.25, pp.543-51, 2004. ,
Évaluation et prise en charge des personnes âgées faisant des chutes répétées, 2009. ,
Epidemiology of osteoporosis-related fractures in France: a literature review, Jt Bone Spine Rev Rhum, vol.77, issue.6, pp.546-51, 2010. ,
L'état de santé de la population en France -rapport, 2008. ,
Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporos Int, vol.16, issue.12, pp.1475-80, 2005. ,
La surveillance épidémiologique des chutes chez les personnes âgées, Bull Epidémiol Hebd, pp.328-363, 2017. ,
De l'importance de prendre en charge l'ostéoporose. Presse Médicale, vol.40, pp.900-909, 20111. ,
Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women, JAMA, vol.301, issue.5, pp.513-534, 2009. ,
The crippling consequences of fractures and their impact on quality of life, Am J Med, vol.103, issue.2, pp.12-21, 1997. ,
Clinical subsequent fractures cluster in time after first fractures, Ann Rheum Dis, vol.68, issue.1, pp.99-102, 2009. ,
Prévalence et caractéristiques de l'ostéoporose dans la population générale en France : l'étude Instant, Rev Rhum, vol.76, issue.7, pp.685-92, 2009. ,
Fragility Fractures and the Osteoporosis Care Gap: An International Phenomenon, Semin Arthritis Rheum, vol.35, issue.5, pp.293-305, 2006. ,
Osteoporosis Medication Use in Nursing Home Patients With Fractures in 1 US State, Arch Intern Med, vol.168, issue.10, pp.1111-1116, 2008. ,
Diagnostic de l'ostéoporose: quels examens biologiques faut-il faire ? Presse Médicale, vol.35, pp.1540-1542, 2006. ,
Utilité clinique du dosage de la vitamine D -Rapport d'évaluation, 2013. ,
, PROTELOS (ranélate de strontium) : prochain arrêt de commercialisation
, , 2017.
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women, Cochrane Database Syst Rev, issue.1, p.1155, 2008. ,
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group, JAMA, vol.282, issue.14, pp.1344-52, 1999. ,
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis, N Engl J Med, vol.356, issue.18, pp.1809-1831, 2007. ,
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N Engl J Med, vol.344, issue.19, pp.1434-1475, 2001. ,
2018 update of french recommendations of the management of postmenopausal osteoporosis, Joint Bone Spine, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01808094
Denosumab for prevention of fractures in postmenopausal women with osteoporosis, N Engl J Med, vol.361, issue.8, pp.756-65, 2009. ,
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density: The Women's Health Initiative Randomized Trial, JAMA, vol.290, issue.13, pp.1729-1767, 2003. ,
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators, JAMA, vol.282, issue.7, pp.637-682, 1999. ,
Prise en charge de l'ostéoporose : la HAS publie une synthèse à destination des professionnels de santé, 2007. ,
European guidance for the diagnosis and management of osteoporosis in postmenopausal women, Osteoporos Int, vol.24, issue.1, pp.23-57, 2013. ,
Dépistage et traitement de l'ostéoporose après la survenue d'une fracture: résultats d'une étude conduite en population générale en Basse-Normandie, 2015. ,
Descriptive study of nursing home residents from the REHPA network, J Nutr Health Aging, vol.13, issue.8, pp.679-83, 2009. ,
Change in hip fracture incidence over the last 6 years in France, Osteoporos Int, vol.22, issue.3, pp.797-801, 2011. ,
Osteoporosis Prevalence and Characteristics of Treated and Untreated Nursing Home Residents With Osteoporosis, J Am Med Dir Assoc, vol.16, issue.4, pp.341-349, 2015. ,
Antiosteoporosis drug prescribing after hip fracture in the UK, Osteoporos Int, vol.26, issue.7, pp.1919-1947, 2000. ,
17 -Faible prévalence du traitement de l'ostéoporose chez des patients avec une récidive de fracture ostéoporotique majeure, Rev Rhum, vol.83, p.52, 2016. ,
Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial, Osteoporos Int, vol.28, issue.5, pp.1549-58, 2017. ,
Management of osteoporosis in women after forearm fracture: Data from a French health insurance database, Joint Bone Spine, vol.82, issue.1, pp.52-57, 2015. ,
Les médecins généralistes connaissent-ils les recommandations de la Société Française de Rhumatologie pour la prise en charge de l'ostéoporose post-ménopausique ? Résultats d'une enquête auprès de 163 médecins généralistes exerçant en Bretagne, Rev Rhum, vol.83, pp.272-275, 2016. ,
La prise en charge médicale de l'ostéoporose après fractures périphériques chez la femme de plus de 50 ans, Rev Rhum, vol.71, issue.3, pp.216-225, 2004. ,
Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between, J Bone Miner Res, vol.29, issue.9, pp.1929-1966, 2002. ,
Priming Primary Care Physicians to Treat Osteoporosis After a Fragility Fracture: An Integrated Multidisciplinary Approach, J Rheumatol, vol.40, issue.5, pp.703-714, 2013. ,
Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture, Arch Intern Med, vol.163, issue.17, pp.2052-2059, 2003. ,
, Fractures liées à une fragilité osseuse : prévention -Premiers Choix Prescrire, actualisation septembre, vol.37, p.929, 2017.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial, The Lancet, vol.391, pp.230-270, 2018. ,
Study of vitamin D supplementation in people over 65 years in primary care, Gériatrie Psychol Neuropsychiatr Viellissement, issue.2, pp.123-132, 2015. ,
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture, J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis, vol.20, issue.6, pp.347-355, 2014. ,
Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture, Am J Med, vol.109, issue.4, pp.326-334, 2000. ,
Les médecins hommes et femmes interagissent de manière différente avec leurs patients : pourquoi s'en préoccuper, Rev Med Suisse, vol.6, pp.1444-1451, 2010. ,
Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons, Mayo Clin Proc, vol.77, issue.4, pp.334-342, 2002. ,
Pratiques, déterminants et obstacles à la prise en charge de l'ostéoporose postménopausique après fracture par des médecins généralistes sarthois, 2014. ,
A Survey of Women's Awareness of and Reasons for Lack of Postfracture Osteoporotic Care, J Am Geriatr Soc, vol.65, issue.8, pp.1829-1864, 2017. ,
Risque d'ostéonécrose des maxillaires avec l'utilisation des bisphosphonates, Rev Médicale Suisse, vol.10, pp.1930-1934, 2014. ,
Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges, Osteoporos Int, vol.24, issue.1, pp.237-281, 2013. ,
, APOROSE | Aide à la Prise en charge de l'OstéopoROSE, 2018.
Pharmacological treatment of osteoporosis in the oldest old, Clin Interv Aging, vol.12, pp.1065-77, 2017. ,
Recommendations for preventing fracture in long-term care, Can Med Assoc J, vol.187, issue.15, pp.1135-1179, 2015. ,
Implementation of Models of Care for secondary osteoporotic fracture prevention and orthogeriatric Models of Care for osteoporotic hip fracture, Best Pract Res Clin Rheumatol, vol.30, issue.3, pp.536-58, 2016. ,
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis, Osteoporos Int, vol.24, issue.2, pp.393-406, 2013. ,
, Groupe de recherche et d'information sur les ostéoporoses. Club Filières et Fractures, 2018.
A systematic review of the effectiveness of interventions to improve postfracture investigation and management of patients at risk of osteoporosis, Implement Sci IS, vol.5, p.80, 2010. ,
Ortho-Geriatric Care Models and Outcomes in Hip Fracture Patients: A Systematic Review and Meta-Analysis, J Orthop Trauma, vol.28, issue.3, pp.49-55, 2014. ,
Orthogériatrie et fracture de la hanche, 2017. ,
Postoperative Admission to a Dedicated Geriatric Unit Decreases Mortality in Elderly Patients with Hip Fracture, PLOS ONE, vol.9, issue.1, p.83795, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01344762
How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study, Osteoporos Int, vol.8, issue.3, pp.247-54, 1998. ,
Impact du recours systématique au médecin traitant sur la réalisation d'une densitométrie osseuse et la mise en route d'un traitement après la survenue d'une fracture à bas niveau d'énergie dépistée dès les urgences. Étude prospective monocentrique sur 434 patients suivis six mois, Rev Rhum, vol.80, issue.6, pp.577-82, 2013. ,
Improving Evaluation and Treatment for Osteoporosis Following Distal Radial Fractures: A Prospective Randomized Intervention, J Bone Jt Surg-Am, vol.90, issue.5, pp.953-61, 2008. ,
, Annexe 6 : recommandation Afssaps, 2006.
, Agence française de sécurité sanitaire des produits de santé, 2006.
, Annexe 8 : fiche « bon usage du médicament » HAS 2014 en cas de fracture ostéoporotique 10
Les Médicaments de L'ostéoporose -Fiche Bon Usage Du Médicament ,
, HAS, 2014.